共 50 条
- [41] Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with Multiple MyelomaPHARMACEUTICS, 2025, 17 (01)Wijnands, CharissaKarel, Peter G. A.Gloerich, JoleinArmony, GadTzasta, AnastasiaAngelino, Corrie M. de KatDi Stefano, LucianoBonifay, VincentLuider, Theo M.Vanduijn, Martijn M.Croockewit, Sandra J.de Kort, Elizabeth A.Castelijn, Daan A. R.Stege, Claudia A. M.Wessels, Hans J. C. T.van Gool, Alain J.van de Donk, Niels W. C. J.Jacobs, Joannes F. M.
- [42] CLONING AND GENETIC-ANALYSIS OF SEROTYPE-5 M-PROTEIN DETERMINANT OF GROUP-A STREPTOCOCCI - EVIDENCE FOR MULTIPLE COPIES OF THE M5 DETERMINANT IN THE STREPTOCOCCUS-PYOGENES GENOMEINFECTION AND IMMUNITY, 1985, 48 (01) : 190 - 197KEHOE, MAPOIRIER, TPBEACHEY, EHTIMMIS, KN
- [43] Assessing clinical response in multiple myeloma (MM) patients treated with monoclonal antibodies (mAbs): Validation of a daratumumab IFE reflex assay (DIRA) to distinguish malignant M-protein from therapeutic antibody.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)McCudden, ChristopherAxel, AmySlaets, DominiqueFrans, SandyBald, JaimeSchecter, Jordan MarkAhmadi, TahamtanPlesner, TorbenSasser, Kate
- [44] QT Interval Effects and M-Protein Response in a Phase 1 Study of Siltuximab (Anti-IL-6 Monoclonal Antibody) in Patients with Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple MyelomaBLOOD, 2012, 120 (21)Thomas, Sheeba K.Suvorov, AlexanderNoens, LucienRukavitsin, OlegFay, JosephWu, Ka LungZimmerman, Todd M.van de Velde, HelgiBandekar, RajeshPuchalski, Thomas A.Qi, MingUhlar, ClarissaSamoilova, Olga S.
- [45] COMPARATIVE STUDY OF ANTIGENS OF STREPTOCOCCUS, GROUP A .2. COMPARATIVE CHARACTERISTICS OF SOME PHYSICOCHEMICAL AND IMMUNOCHEMICAL PROPERTIES OF PARTIALLY-PURIFIED M-PROTEIN AND CYTOPLASMIC PROTECTIVE ANTIGENZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1976, (01): : 91 - 96EVSEEV, VAKONDRASHOV, GIAVDEEVA, ZINOVOSARDOV, VL
- [46] Comparative Analysis of sSLAMF7, sBCMA, and M-Protein As Prognostic, Predictive, and Pharmacodynamic Biomarkers in Relapsed/Refractory Multiple Myeloma Treated with Pomalidomide and Dexamethasone plus /- ElotuzumabBLOOD, 2019, 134Forslund, AnnTang, HaoDuan, ChunzhePopa-McKiver, MihaelaBerenson, James R.Robbins, Michael
- [47] DISTINCT IGG1 AND IGG3 SUBCLASS RESPONSES TO 2 STREPTOCOCCAL PROTEIN ANTIGENS IN MAN - ANALYSIS OF ANTIBODIES TO STREPTOLYSIN-O AND M-PROTEIN USING STANDARDIZED SUBCLASS-SPECIFIC ENZYME-LINKED IMMUNOSORBENT ASSAYSIMMUNOLOGY, 1993, 79 (01) : 89 - 94FALCONER, AECARSON, RJOHNSTONE, RBIRD, PKEHOE, MCALVERT, JE
- [48] Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment (vol 37, pg 1, 2023)LEUKEMIA, 2024, 38 (08) : 1863 - 1863Claveau, Jean-SebastienMurray, David L.Dispenzieri, AngelaKapoor, PrashantBinder, MoritzBuadi, FrancisDingli, DavidFonder, AmieGertz, MorieGonsalves, WilsonHayman, SuzanneHobbs, MiriamHwa, Yi LisaKourelis, TaxiarchisLacy, MarthaLeung, NelsonLin, YiWarsame, RahmaKyle, Robert A.Rajkumar, VincentKumar, Shaji K.
- [49] AUTOANTIBODY GERM-LINE GENE SEGMENT ENCODES V-H AND V-L REGIONS OF A HUMAN ANTISTREPTOCOCCAL MONOCLONAL-ANTIBODY RECOGNIZING STREPTOCOCCAL M-PROTEIN AND HUMAN CARDIAC MYOSIN EPITOPESJOURNAL OF IMMUNOLOGY, 1995, 154 (08): : 4203 - 4212QUINN, AADDERSON, EESHACKELFORD, PGCARROLL, WLCUNNINGHAM, MW